Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog

The hallmark of type 1 diabetes is autoimmune destruction of the insulin-producing β-cells of the pancreatic islets. Autoimmune diabetes has been difficult to study or treat because it is not usually diagnosed until substantial β-cell loss has already occurred. Imaging agents that permit noninvasive visualization of changes in β-cell mass remain a high-priority goal. We report on the development and testing of a near-infrared fluorescent β-cell imaging agent. Based on the amino acid sequence of exendin-4, we created a neopeptide via introduction of an unnatural amino acid at the K12 position, which could subsequently be conjugated to fluorophores via bioorthogonal copper-catalyzed click-chemistry. Cell assays confirmed that the resulting fluorescent probe (E4×12-VT750) had a high binding affinity (∼3 nM). Its in vivo properties were evaluated using high-resolution intravital imaging, histology, whole-pancreas visualization, and endoscopic imaging. According to intravital microscopy, the probe rapidly bound to β-cells and, as demonstrated by confocal microscopy, it was internalized. Histology of the whole pancreas showed a close correspondence between fluorescence and insulin staining, and there was an excellent correlation between imaging signals and β-cell mass in mice treated with streptozotocin, a β-cell toxin. Individual islets could also be visualized by endoscopic imaging. In short, E4×12-VT750 showed strong and selective binding to glucose-like peptide-1 receptors and permitted accurate measurement of β-cell mass in both diabetic and nondiabetic mice. This near-infrared imaging probe, as well as future radioisotope-labeled versions of it, should prove to be important tools for monitoring diabetes, progression, and treatment in both experimental and clinical contexts.

[1]  S. Gambhir,et al.  Multimodality Imaging of β-Cells in Mouse Models of Type 1 and 2 Diabetes , 2011, Diabetes.

[2]  T. E. Hall,et al.  A novel fluorescence imaging approach for comparative measurements of pancreatic islet function in vitro , 2011, Islets.

[3]  Simon K Lo,et al.  The learning curve of in vivo probe-based confocal laser endomicroscopy for prediction of colorectal neoplasia. , 2009, Gastrointestinal endoscopy.

[4]  Ting-Yim Lee,et al.  Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy , 2011, Molecular Imaging and Biology.

[5]  Greg M. Thurber,et al.  Detection limits of intraoperative near infrared imaging for tumor resection , 2010, Journal of surgical oncology.

[6]  K. Wanic,et al.  The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. , 2010, The Journal of clinical investigation.

[7]  C. Rolny,et al.  Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle , 2010, Diabetes.

[8]  J. Gaglia,et al.  Near-infrared fluorescent probe for imaging of pancreatic beta cells. , 2010, Bioconjugate chemistry.

[9]  A. Saftoiu,et al.  Confocal laser endomicroscopy of the colon. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[10]  R. Veluthakal,et al.  In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective. , 2010, Current pharmaceutical design.

[11]  James Sharpe,et al.  Quantification and Three-Dimensional Imaging of the Insulitis-Induced Destruction of β-Cells in Murine Type 1 Diabetes , 2010, Diabetes.

[12]  M. Gotthardt,et al.  Approaches for imaging islets: recent advances and future prospects. , 2010, Advances in experimental medicine and biology.

[13]  Intraoperative Near-infrared Fluorescent Cholangiography (NIRFC) in Mouse Models of Bile Duct Injury: Reply , 2010, World Journal of Surgery.

[14]  Ralph Weissleder,et al.  Intraoperative Near-Infrared Fluorescent Cholangiography (NIRFC) in Mouse Models of Bile Duct Injury , 2010, World Journal of Surgery.

[15]  W. Malaisse,et al.  Noninvasive imaging of pancreatic β cells , 2009, Nature Reviews Endocrinology.

[16]  B. Ahrén Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes , 2009, Nature Reviews Drug Discovery.

[17]  E. Montanya,et al.  Pancreatic remodeling: beta-cell apoptosis, proliferation and neogenesis, and the measurement of beta-cell mass and of individual beta-cell size. , 2009, Methods in molecular biology.

[18]  R. Weissleder,et al.  In vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe. , 2008, Translational oncology.

[19]  M. V. von Herrath,et al.  Real‐time imaging of the pancreas during development of diabetes , 2008, Immunological reviews.

[20]  M. Freeby,et al.  VMAT2 gene expression and function as it applies to imaging beta-cell mass. , 2008, Journal of molecular medicine.

[21]  James Sharpe,et al.  Tomographic molecular imaging and 3D quantification within adult mouse organs , 2007, Nature Methods.

[22]  M. Freeby,et al.  VMAT2 gene expression and function as it applies to imaging β-cell mass , 2007, Journal of Molecular Medicine.

[23]  M. Freeby,et al.  Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas. , 2006, Current medicinal chemistry.

[24]  R. V. Van Heertum,et al.  Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. , 2006, The Journal of clinical investigation.

[25]  R. Weissleder,et al.  Development of a dual fluorogenic and chromogenic dipeptidyl peptidase IV substrate. , 2006, Bioorganic & medicinal chemistry letters.

[26]  Yoshihiro Kawano,et al.  Novel multiwavelength microscopic scanner for mouse imaging. , 2005, Neoplasia.

[27]  A. Alavi,et al.  In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[28]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[29]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[30]  Habib Zaidi,et al.  Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. , 2005, Transplantation.

[31]  Å. Lernmark,et al.  Systematic screening of potential β-cell imaging agents , 2004 .

[32]  Å. Lernmark,et al.  Systematic screening of potential beta-cell imaging agents. , 2004, Biochemical and biophysical research communications.

[33]  G. Bell,et al.  Transgenic mice with green fluorescent protein-labeled pancreatic beta -cells. , 2003, American journal of physiology. Endocrinology and metabolism.

[34]  G. Bell,et al.  Transgenic mice with green fluorescent protein-labeled pancreatic β-cells , 2003 .

[35]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[36]  Y. Miyashita,et al.  Two-photon excitation imaging of pancreatic islets with various fluorescent probes. , 2002, Diabetes.

[37]  R. Weissleder,et al.  Noninvasive In Vivo Measurement of β-Cell Mass in Mouse Model of Diabetes , 2001 .

[38]  R. Weissleder,et al.  Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. , 2001, Diabetes.

[39]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[40]  H. Sakahara,et al.  Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities. , 2000, Clinical nuclear medicine.

[41]  P. Rorsman,et al.  Stimulation of cloned human glucagon‐like peptide 1 receptor expressed in HEK 293 cells induces cAMP‐dependent activation of calcium‐induced calcium release , 1995, FEBS letters.

[42]  B. Thorens,et al.  Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. , 1995, The Biochemical journal.

[43]  J. Miyazaki,et al.  Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. , 1990, Endocrinology.

[44]  A. Rossini,et al.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.